Efficacy and Safety of Efdamrofusp Alfa with Personalized Dosing Intervals in Neovascular Age-Related Macular Degeneration: A Phase II Trial
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Shujie Lu
- Jianping Tong (ORCID: https://orcid.org/0000-0002-1562-6749)
- Huixun Jia (ORCID: https://orcid.org/0000-0001-9341-5587)
- Xiaodong Sun (ORCID: https://orcid.org/0000-0001-5015-0945)
- Ji‐Long Hao (ORCID: https://orcid.org/0000-0002-5295-5752)
- Haiwei Du (ORCID: https://orcid.org/0000-0002-4329-2088)
- Qinghuai Liu (ORCID: https://orcid.org/0000-0003-1605-1964)
- Han Han-Zhang
- Rongrong Zhu (ORCID: https://orcid.org/0000-0002-3519-7566)
- Tong Li (ORCID: https://orcid.org/0000-0002-2544-1254)
- Xiaoyu Chen (ORCID: https://orcid.org/0000-0003-4009-8156)
- Wei Wang (ORCID: https://orcid.org/0000-0002-5273-3332)
- Weiqi Chen (ORCID: https://orcid.org/0000-0003-2852-8192)
- Wang Yf (ORCID: https://orcid.org/0000-0001-7737-1406)
- Jinglin Zhang (ORCID: https://orcid.org/0000-0002-9801-9847)
- Shiqi Yang (ORCID: https://orcid.org/0000-0003-1314-951X)
- Wenbin Wei (ORCID: https://orcid.org/0000-0002-9361-6159)
- Guohong Zhou (ORCID: https://orcid.org/0009-0005-7020-0790)
- Chaopeng Li (ORCID: https://orcid.org/0000-0002-6656-8331)
- Xuan Xiao (ORCID: https://orcid.org/0000-0001-7762-8689)
- Junran Sun (ORCID: https://orcid.org/0000-0001-6545-5223)
- Yanping Song (ORCID: https://orcid.org/0000-0002-9666-5482)
- Hong Dai (ORCID: https://orcid.org/0000-0002-9819-8750)
- Jie Zhang (ORCID: https://orcid.org/0000-0002-6802-9251)
- Ying Wen
- Haoyu Li
Institutions
- Beijing Tongren Hospital (CN)
- Shanghai Jiao Tong University (CN)
- Capital Medical University (CN)
- Nantong University (CN)
- Shantou University (CN)
- Wuhan University (CN)
- Affiliated Hospital of Nantong University (CN)
- Huaian First People’s Hospital (CN)
- Weifang People's Hospital (CN)
- Beijing Hospital (CN)
- Zhejiang Provincial People's Hospital (CN)
- Shanxi Eye Hospital (CN)
- Shanghai First People's Hospital (CN)
- Hebei Eye Hospital (CN)
- Renmin Hospital of Wuhan University (CN)
- Central Hospital of Wuhan (CN)
- First Bethune Hospital of Jilin University (CN)
- Wuhan General Hospital of Guangzhou (CN)
- He Eye Hospital (CN)
- Shandong Shierming Eye Hospital (CN)
- US Biologic (United States) (US)
- Weifang Chinese Medicine Hospital (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Ophthalmology Science
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1016/j.xops.2025.100913
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71
Funders
- Innovent Biologics